Pall T. Onundarson Urges You to Watch It: Emerging Anticoagulants and Reversal Agents What’s Next in the Pipeline?
Pall T. Onundarson, Professor Emeritus at Landspitali University Hospital, recently shared on LinkedIn, reposting from Anticoagulation Forum:
”Something to think about. Great savings if you want them.”
Anticoagulation Forum posted on Emerging Anticoagulants on LinkedIn:
‘Missed it live? Now’s your chance to catch up — or rewatch! The recording of our recent webinar, Emerging Anticoagulants and Reversal Agents: What’s Next in the Pipeline?, is now available! Watch it here.
As the anticoagulation field continues to evolve, this session delivers expert insights into investigational agents and reversal strategies that may soon impact clinical practice. If you manage complex patients or influence clinical policy, this is one to watch.
Webinar highlights:
- Latest clinical trial data
- Future applications in stroke prevention, dialysis, oncology, and device-related thrombosis
- Practical considerations for frontline care and system-level planning
We are grateful to our speakers and panelists for a fantastic discussion:
Geoffrey Barnes, MD, MSc
Gabe Fontaine PharmD, MBA, BCCCP, BCPS, FNCS, FCCM
Jean Connors, MD
Arthur Allen, PharmD, CACP (Moderator)
Jori May, MD (Moderator)
Free for AC Forum members — membership is quick and free to join. Explore this and hundreds of additional resources to enhance your practice.”
Join AC Forum.
Stay tuned to not miss out on all webinars in the field of coagulation with Hemostasis Today.
-
Nov 3, 2025, 08:23The 1st Participant in A New CHECK-NIRS Clinical Study is Enrolled!
-
Nov 3, 2025, 08:15Bert van Meurs Shares the New Late-breaking Results from the iMODERN Trial
-
Nov 3, 2025, 07:10Lisa Shea Shares Key Takeaways from NORD Summit 2025
-
Nov 3, 2025, 06:49Darshan Doshi on Results of iMODERN and ILIAS ANOCA Studies Presented at TCT 2025
-
Nov 2, 2025, 14:172019 ESC/EAS Guidelines for the Management of Dyslipidaemias Discussion with Lale Tokgözoğlu and Jeanine Roeters van Lennep
-
Nov 3, 2025, 09:13Claudio Carrubba on How Timing Truly Matters in Trauma Embolization
-
Nov 3, 2025, 08:46Rachel Lamerton and Colleagues on Activation of Platelets in Flow Cytometry
-
Nov 3, 2025, 04:56Nirupama Ramadas and Erica Sparkenbaugh on Thromboinflammation in SCD
-
Nov 2, 2025, 14:21Claude Franceschi: I Advise You to Understand the Hemodynamic Pathophysiology of Venous Diseases Rather than Blindly Applying Ablation Techniques or Venous Stent Placement
-
Nov 2, 2025, 14:15Krishna Aragam: Why are (DCM) and Heart Failure About Twice as Common in Individuals of Self-Identified Black Race?
-
Oct 29, 2025, 07:31The Use of Artificial Intelligence to Improve Detection of Acute Incidental Pulmonary Emboli - JTH
-
Oct 29, 2025, 07:05Shrinidhi Nathany: AI in Diagnostic Medicine
-
Oct 28, 2025, 07:02Aya Berman: AI Model for Predicting Bacteremia
-
Oct 28, 2025, 06:55The New Era of Genomics, AI and Cell Therapy in Hematology and Infectious Diseases
-
Oct 28, 2025, 06:49Lukas Gaats: Researchers Are Building Reproductive Organoids
-
Nov 3, 2025, 09:24Stephen Cornelissen: It’s Not Just About Emergencies — It’s About Everyday Care, Chronic Conditions and Hope
-
Nov 3, 2025, 06:57Maria Elisa Mancuso Reflects on 2025 Annual Congress of the Italian Association of Hemophilia Centres
-
Nov 3, 2025, 05:46Chandra Viswanathan: When Blood Safety Fails, We All Bleed - A Call for Reform and Responsibility
-
Nov 2, 2025, 14:17Anamaria B: Your Mother Still Runs Part of Your DNA
-
Nov 2, 2025, 10:57Paul Bolaji on Launching The First Centralised Nigerian National Stroke Registry